Heart Failure Treatment and Management
Moving in European Heart Journal and Med.
- Moved, week to 18 Nov 2026
- 2
- Papers in 60 days
- 102
Rebuilt
Moved this week
AI summary · may contain errors
Heart failure with reduced ejection fraction remains a major burden because contractile dysfunction is not corrected by GDMT, and conventional inotropes improve contractility but worsen outcomes.
- Open access
- 3 cites
Latest in Heart Failure Treatment and Management
Newest first · last 60 days
AI summary · may contain errors
In a retrospective cohort of chronic heart failure patients (n=1.180), OUES absolute and percent-predicted values predicted all-cause mortality similarly, with AUCs of 0.71–0.72 in males and 0.60–0.63 in females.
- Open access
AI summary · may contain errors
In adults with non-dialysis CKD stages G1–G5 already on ACEi/ARB, adding a thiazide diuretic was linked to lower cardiovascular event risk than calcium channel blockers, β-blockers, or loop diuretics.
AI summary · may contain errors
In patients with stage 5 chronic kidney disease, SGLT2 inhibitor use is linked to fewer heart failure hospitalizations (HR 0.78; 95% CI 0.72–0.85).
- Open access
AI summary · may contain errors
In the FINE-HEART pooled analysis of 18 991 advanced cardiovascular-kidney-metabolic participants, women had higher multimorbidity and lower all-cause mortality risk (adjusted HR 0.83).
- Open access
- 9 cites
AI summary · may contain errors
CiRPM after hospitalization for acutely decompensated cirrhosis is linked to fewer 90-day liver-related readmissions versus C-control (39% vs 58%, HR 0.57, p=0.01).
AI summary · may contain errors
Semaglutide 2.4 mg weekly reduced invasively measured pulmonary artery wedge pressure during exercise by -9.8 mmHg versus +0.9 mmHg with placebo in 81 HFpEF patients with obesity.
AI summary · may contain errors
Early palliative care for adults with advanced cardiovascular disease improves symptom control and quality of life, and is linked to less psychological distress and reduced high-intensity, low-value end-of-life care.
- 3 cites
AI summary · may contain errors
In HFrEF patients (LVEF ≤40%) on contemporary therapy, hydralazine–isosorbide dinitrate did not reduce the composite rate of heart failure events or death (30.6% vs 30.5%).
AI summary · may contain errors
In adults with congenitally corrected transposition of the great arteries and systemic right ventricular systolic dysfunction, higher baseline and uptitrated GDMT scores are linked to improved RV free wall strain and lower mortality.
AI summary · may contain errors
In a southern Sweden cohort of 19,892 people with newly diagnosed diabetes (excluding type 1), 4.8% developed all-cause heart failure over median 5.0 years.
- Open access
AI summary · may contain errors
A fixed-dose heart failure with reduced ejection fraction polypill is being tested in Sri Lanka to assess feasibility, medication adherence effects, and safety versus usual care.
- Open access
- 1 cites
AI summary · may contain errors
Undiagnosed chronic kidney disease is prevalent in high-risk patients with heart failure enrolled in the FINEARTS-HF randomized clinical trial, and it is linked to cardiovascular outcomes.
- Open access
AI summary · may contain errors
Nondialyzable β-blockers at hemodialysis initiation are linked to lower 6-month, 1-year, and 3-year MACE risk versus dialyzable β-blockers, with hazard ratios down to 0.82.
- Open access
- 6 cites
AI summary · may contain errors
Increasing cardiovascular-kidney-metabolic multimorbidity among US patients hospitalized for heart failure is linked to stepwise higher mortality and readmission, strongest in HFrEF.
- Open access
AI summary · may contain errors
In 2023, global estimates for heart failure across 204 countries and territories show 56.0 million cases (95% UI 49.9–62.2 million), with prevalence rising by age.
- Open access
- 1 cites
AI summary · may contain errors
A global multisociety harmonisation initiative has produced a unified, evidence-based framework for defining, diagnosing, grading, and managing acute-on-chronic liver failure (ACLF) worldwide.
AI summary · may contain errors
Rural patients hospitalized in urban hospitals after HFrEF admission received more cardiology consultation and GDMT initiation and had lower 1-year HF readmission (OR 0.85) than rural-rural patients.
- Open access
AI summary · may contain errors
A global multisociety harmonisation initiative has produced a unified, evidence-based framework for defining, diagnosing, grading, and managing acute-on-chronic liver failure (ACLF) worldwide.
- Open access
Browse JClub
Journals this month
- bioRxiv6485
- medRxiv1747
- PNAS583
- JAMA366
- Sci Adv330
- Cell Rep321
- Environ Res230
- BMJ216
- EHJ208
- NAR176
- Plant Cell Environ173
- Nat Commun166
- Science152
- Environ Pollution151
- NEJM148
- New Phytol148
- Lancet129
- Nature127
Topics moving, week to 18 Nov 2026
- Gut microbiota and health9
- Single-cell and spatial transcriptomics6
- CAR-T cell therapy research4
- Global Cancer Incidence and Screening3
- Lung Cancer Treatments and Mutations3
- Pancreatic and Hepatic Oncology Research3
- Antibiotic Resistance in Bacteria3
- Bacteriophages and microbial interactions3
- Diabetes Management and Education3
- Immune cells in cancer3
By field
- General Science & Medicine22
- Clinical Medicine25
- Cardiology & Vascular Biology12
- Endocrinology & Metabolism10
- Gastroenterology & Hepatology7
- Public & Global Health4
- Cell & Molecular Biology30
- Immunology & Inflammation14
- Neuroscience14
- Psychiatry & Mental Health8
- Genomics & Bioinformatics29
- Pharmacology & Drug Discovery5
- Microbiology & Mycology34
- Oncology22
- Ecology & Evolution5
- Protected Cropping & Horticultural Science5
- Plant Physiology & Photobiology19
- Student Research1
